Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
Artemisinin, Nrf2, and Ferroptosis in Diabetic Cognition
2026-08-20
Wang et al. show that artemisinin improves cognitive performance in streptozotocin-induced type 2 diabetes mellitus mice while reducing hippocampal neuronal ferroptosis. Pharmacological blockade with ML385 and induction with erastin weakened these benefits, supporting a mechanistic link between Nrf2 activation, antioxidant defense, and ferroptosis suppression.
HyperTrap Heparin HP Column for Protein Purification
2026-08-19
The HyperTrap Heparin HP Column is a preloaded affinity chromatography column containing HyperChrom Heparin HP Agarose. Its 34 μm particles, approximately 10 mg/mL ligand density, broad medium stability, and flexible operation support high-resolution purification of heparin-binding proteins.
Surrogate BBB Model for High-Throughput CNS Screening
2026-08-19
Hu and colleagues developed a Transwell blood-brain barrier surrogate that combines LLC-PK1-MOCK and LLC-PK1-MDR1 cells with a correction strategy for lysosomal drug trapping. By linking bidirectional permeability data with unbound brain distribution, the study supports faster, mechanism-aware prioritization of central nervous system candidates while clarifying important limitations of simplified barrier models.
DIDS and the Translational Logic of Cell Stress
2026-08-18
DIDS is more than a chloride transport probe: it is a strategic perturbation tool for testing how ion handling, near-death survival, ER stress, and tissue-specific signaling shape translational phenotypes. This article connects DIDS pharmacology with prometastatic tumor states, vascular physiology, neuroprotection, and rigorous experimental design.
AMD-070 Hydrochloride CXCR4 Antagonist Workflows
2026-08-18
Build more discriminating CXCR4 assays with AMD-070 hydrochloride by pairing receptor-pathway readouts with migration, viability, and membrane-integrity controls. The workflow also translates a classic protoplast-stabilization study into practical safeguards for anti-HIV research, hematopoietic models, and HIV entry inhibition.
L-Phenylephrine in α1A Cardiovascular Research
2026-08-17
L-Phenylephrine provides a defined adrenergic α1A receptor agonist system for connecting vasoconstriction, baroreflex physiology, cardiomyocyte stress responses, and gene-expression assays. This workflow translates sex-specific hypertension findings into practical in vitro and in vivo experimental designs with explicit controls and troubleshooting steps.
GDC-0994: Reading ERK1/2 Signaling in Context
2026-08-17
GDC-0994 is a selective ERK1/2 inhibitor for separating pathway activation from downstream biological effects. This guide translates cancer and zebrafish cholestasis findings into practical assay and interpretation strategies.
6-Thioguanine and EV71: BIRC3-Linked Autophagy
2026-08-16
The reference study identifies 6-thioguanine as an in vitro inhibitor of Enterovirus 71 replication and links this activity to reduced BIRC3 expression and suppression of complete autophagy. Its concentration-response and mechanistic findings provide a useful framework for evaluating repurposed antineoplastic agents in antiviral research, while remaining limited to cell-based evidence.
Capsazepine Workflows for TRPV1 Research
2026-08-15
Capsazepine provides a controllable pharmacological route to test TRPV1-dependent calcium signaling, nociception inhibition, and sensory-neuron responses. This guide translates a recent cannabidiol pain study into practical antagonist-control experiments while also addressing TRPM8 channel inhibition, formulation, selectivity, and apoptosis research.
KPT-330 and the Translational Logic of CRM1 Inhibition
2026-08-14
CRM1 inhibition offers a mechanistically grounded strategy for restoring nuclear control over tumor suppressors and stress responses. This thought-leadership perspective examines how KPT-330 (Selinexor) can support biomarker-led cancer research, combination design, and more disciplined translation from models to therapeutic hypotheses.
Thermosensitive ROS-Scavenging Hydrogel for Diabetic Wounds
2026-08-14
The reference study introduces TGF-β1@MATH, an adhesive thermosensitive hydrogel that combines ROS-scavenging MnO2 nanozymes with controlled TGF-β1 delivery and temperature-dependent stiffening. In diabetic mice, this integrated design improved re-epithelialization, collagen deposition, angiogenesis, and regulatory T-cell recruitment, providing a mechanistically coordinated approach to chronic wound repair.
Hoechst 33342 for Senescence Assay Design
2026-08-13
Learn how Hoechst 33342 nuclear stain can strengthen live and fixed-cell senescence workflows without being mistaken for a senescence marker. This guide connects nuclear quality control, mitochondrial readouts, and the 2025 dermal fibroblast study by Zhou et al. to practical assay decisions.
Live-Dead Cell Staining Kit: Practical Guide
2026-08-13
Learn how Calcein-AM and Propidium Iodide dual staining supports reproducible cell viability assays in microscopy, flow cytometry, cytotoxicity studies, and biomaterial screening. This workflow-focused guide also explains how to interpret viability data in the context of the 2025 GelMA/QCS/Ca2+ hemostatic adhesive study.
CSRP2–PDGFRA Signaling in Glioma
2026-08-12
A 2026 study identifies CSRP2 as a mesenchymal glioma-associated regulator that connects PRC1-linked promoter remodeling with PDGFRA/PI3K/AKT signaling. Its integrated genomic, epigenomic, cellular, and xenograft analyses provide a mechanistic framework for interpreting CSRP2 as a biomarker candidate, while therapeutic relevance remains unresolved.
Merimepodib (VX-497): IMPDH Assay Logic
2026-08-12
Merimepodib (VX-497) offers a powerful way to interrogate guanine nucleotide dependence across antiviral and immune models. This article explains how recent PEDV research can improve assay design, controls, and interpretation beyond simple compound screening.
8548 records 11/570 page Previous Next First page 上5页 1112131415 下5页 Last page